SeaCrest Wealth Management LLC Invests $192,000 in Walgreens Boots Alliance Inc (WBA) Stock
SeaCrest Wealth Management LLC bought a new position in Walgreens Boots Alliance Inc (NASDAQ:WBA) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 2,639 shares of the pharmacy operator’s stock, valued at approximately $192,000.
A number of other hedge funds and other institutional investors have also modified their holdings of WBA. Commonwealth Bank of Australia raised its holdings in shares of Walgreens Boots Alliance by 139.5% during the second quarter. Commonwealth Bank of Australia now owns 46,167 shares of the pharmacy operator’s stock valued at $3,614,000 after buying an additional 26,893 shares during the last quarter. Andra AP fonden raised its holdings in shares of Walgreens Boots Alliance by 6.9% during the third quarter. Andra AP fonden now owns 62,300 shares of the pharmacy operator’s stock valued at $4,811,000 after buying an additional 4,000 shares during the last quarter. Birinyi Associates Inc. raised its holdings in shares of Walgreens Boots Alliance by 9.0% during the second quarter. Birinyi Associates Inc. now owns 9,100 shares of the pharmacy operator’s stock valued at $713,000 after buying an additional 750 shares during the last quarter. Chesley Taft & Associates LLC raised its holdings in shares of Walgreens Boots Alliance by 48.6% during the fourth quarter. Chesley Taft & Associates LLC now owns 261,369 shares of the pharmacy operator’s stock valued at $18,981,000 after buying an additional 85,423 shares during the last quarter. Finally, CI Investments Inc. bought a new stake in shares of Walgreens Boots Alliance during the third quarter valued at approximately $27,555,000. 61.57% of the stock is currently owned by hedge funds and other institutional investors.
In other news, insider Stefano Pessina acquired 98,858 shares of the stock in a transaction on Monday, January 15th. The shares were purchased at an average cost of $76.07 per share, for a total transaction of $7,520,128.06. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 14.80% of the company’s stock.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share for the quarter, topping the consensus estimate of $1.27 by $0.01. Walgreens Boots Alliance had a net margin of 3.19% and a return on equity of 19.15%. The firm had revenue of $30.74 billion for the quarter, compared to analysts’ expectations of $30.39 billion. During the same period in the previous year, the company posted $1.10 EPS. The company’s quarterly revenue was up 7.9% compared to the same quarter last year. equities analysts forecast that Walgreens Boots Alliance Inc will post 5.71 EPS for the current year.
Walgreens Boots Alliance declared that its board has authorized a stock repurchase program on Wednesday, October 25th that permits the company to buyback $1.00 billion in outstanding shares. This buyback authorization permits the pharmacy operator to repurchase shares of its stock through open market purchases. Stock buyback programs are often an indication that the company’s board believes its stock is undervalued.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 12th. Shareholders of record on Thursday, February 15th will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 2.34%. The ex-dividend date of this dividend is Wednesday, February 14th. Walgreens Boots Alliance’s payout ratio is 44.20%.
WBA has been the topic of a number of recent analyst reports. Deutsche Bank initiated coverage on Walgreens Boots Alliance in a report on Monday, December 4th. They set a “hold” rating and a $78.00 price target on the stock. Leerink Swann cut Walgreens Boots Alliance from an “outperform” rating to a “market perform” rating in a report on Wednesday, November 1st. Zacks Investment Research raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $85.00 price target on the stock in a report on Sunday, January 21st. Loop Capital set a $90.00 price target on Walgreens Boots Alliance and gave the company a “buy” rating in a report on Thursday, October 26th. Finally, Pivotal Research lowered their price objective on shares of Walgreens Boots Alliance from $85.00 to $73.00 and set a “hold” rating on the stock in a research note on Tuesday, October 24th. Eleven investment analysts have rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average target price of $85.53.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.